Article Details
Retrieved on: 2022-03-08 00:15:40
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
-First-in-Class Anti-PVR (CD155) Monoclonal Antibody NTX1088 Induces Anti-Tumor Immunity with Unique Triple Mechanism of Action Designed to ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here